Back to today’s briefing

Story perspectives

FDA Approves Non-Addictive Painkiller Amid Safety Concerns

5/30/2025

33 3

Summary

Story summary

Suzetrigine, a groundbreaking non-addictive painkiller approved by the FDA, may help combat opioid dependency, as revealed by a Tebra survey. Yet, a significant 72% of healthcare providers worry about its long-term safety. In a related note, the American Dental Association plans to host its last SmileCon conference in Washington, D.C., from October 23-25, 2026, amid dwindling attendance.

1 of 1

Story summary

Suzetrigine, a groundbreaking non-addictive painkiller approved by the FDA, may help combat opioid dependency, as revealed by a Tebra survey. Yet, a significant 72% of healthcare providers worry about its long-term safety. In a related note, the American Dental Association plans to host its last SmileCon conference in Washington, D.C., from October 23-25, 2026, amid dwindling attendance.